Videoconferencing Facility; Availability

Короткий зміст

The Food and Drug Administration (FDA) is announcing the availability of a videoconferencing facility. The videoconferencing facility was established to improve communications between the agency and interested parties. The facility will be used for a variety of purposes, including meetings, with the public and regulated industries, internal FDA meetings, and training. The facility will be used to supplement face-to-face meetings and allow broader participation in discussions with FDA.